Last reviewed · How we verify
D337(placebo)
D337 is a placebo control with no active pharmacological mechanism.
At a glance
| Generic name | D337(placebo) |
|---|---|
| Sponsor | Chong Kun Dang Pharmaceutical |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
As a placebo, D337 contains no active pharmaceutical ingredient and produces no direct molecular or therapeutic effect. It is used as a control comparator in clinical trials to assess the efficacy and safety of active investigational drugs by comparison against an inert substance.
Approved indications
Common side effects
Key clinical trials
- Clinical Trial to Evaluate the Efficacy and Safety of CKD-386 (PHASE3)
- Clinical Study to Evaluate the Efficacy and Safety of CKD-348(CKD-828, D326, D337) Tablet (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |